NEW YORK (GenomeWeb News) – Agilent Technologies said today that it plans to collaborate with the University of Queensland Centre for Clinical Research in Brisbane, Australia in an exome sequencing study of oral cancer patients.

The goal of the collaboration is to understand the genomic differences between young and older patients and between progressive and non-progressive lesions. Both young and older patients with oral squamous cell carcinoma as well as young and older patients with oral potentially malignant lesions will be studied.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.